Illumina, Broad Clinical Labs Partner to Expedite Single-Cell Research

MT Newswires Live
21 Feb

Illumina (ILMN) said Friday it is collaborating with Broad Clinical Labs to expedite single-cell research.

The partnership aims to create a 5 billion cell atlas ecosystem within three years, the company said.

Financial details were not disclosed.

Price: 97.07, Change: -0.14, Percent Change: -0.14

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10